comparemela.com

Latest Breaking News On - Careggi university hospital - Page 10 : comparemela.com

Jason Dupasquier: Moto3 rider dies aged 19 after Mugello qualifying crash

Moto3 riderJason Dupasquier has tragically died aged just 19 after suffering a serious crash during qualifying in Mugello, Italy. The Swiss PruestelGP rider was involved in a serious three-bike accident between turns nine and 10 during Qualifying 2 for the Gran Premio d’Italia Oakley on Saturday and was treated on the track with the session red-flagged before being airlifted to Careggi University Hospital in Florence. On Sunday morning, MotoGP.

ACP OKs Add-On Ultrasound for Pinpointing Acute Dyspnea

Apr 27, 2021 Clinical guide green lights point-of-care imaging with standard diagnosis in ED, inpatient settings Clinicians can use add-on point-of-care ultrasonography in patients with unspecified acute dyspnea in the emergency department (ED) or inpatient setting, according to the American College of Physicians (ACP), although the recommendation is based on a low certainty of evidence. Combining point-of-care ultrasonography (POCUS) with the standard diagnostic pathway increased the proportion of correct diagnoses by 32%, boosted the sensitivity of standard testing without “a substantial tradeoff in specificity,” did not seem to be tied to any serious harms, is not a high-cost test, and did not result in a longer length of stay (LOS) for patients, wrote Amir Qaseem, MD, PhD, MHA, of the ACP in Philadelphia, and co-authors on the college’s clinical guidelines committee.

B cell activating factor possible key to hemophilia immune tolerance

 E-Mail A group of scientists have just made a key discovery that could prevent and eradicate immune responses that lead to treatment failure in about one-third of people with severe hemophilia A. Hemophilia is the most common severe inherited bleeding disorder in men. The disease affects 1 in 10,000 males worldwide and results from deficiency of blood clotting factor VIII (FVIII). Both children and adults with hemophilia A (80 percent of all hemophilia) receive treatment that involves infusing FVIII protein into the bloodstream. However, about 30 percent of them develop an immune response in the form of antibodies to FVIII (inhibitors), rendering treatment ineffective and increasing risk of mortality.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.